Literature DB >> 7848985

Improved preservation of human corneal basement membrane following freezing of donor tissue for epikeratophakia.

R D Young1, W J Armitage, P Bowerman, S D Cook, D L Easty.   

Abstract

Current methods for the production of lenticules for epikeratophakia involve rapid freezing, cryolathing, and slow warming of the donor cornea. We have found that this procedure causes structural damage to the epithelial basement membrane in the donor cornea which may subsequently contribute to poor postoperative re-epithelialisation of the implant, leading to graft failure. Endeavouring to overcome these problems, the effects of cryoprotection of donor cornea were investigated, using dimethyl sulphoxide, in conjunction with different cooling and warming rates as part of the protocol for cryolathing. The structural integrity of the epithelial basement membrane zone (BMZ) was then assessed by electron microscopy and by immunofluorescence microscopy using antibodies to types IV and VII collagen, components of the basal lamina and anchoring fibrils respectively, and an antibody to a component of the anchoring filaments. No differences in the pattern of immunostaining for these components were detected, indicating that the composition of the BMZ was unaltered by the different treatment regimens applied. However, electron microscopy showed that preservation of basement membrane ultrastructure was markedly improved when cornea was warmed rapidly rather than slowly, both in cryoprotected and non-cryoprotected tissue. Epithelial cell retention and preservation of stromal architecture appeared superior in cryoprotected samples, while keratocyte structure was heterogeneous throughout the experimental groups. Further work is in progress to assess the efficacy of these protocols in the preservation of keratocyte viability in association with improved basement membrane structure in donor tissue for epikeratophakia.

Entities:  

Mesh:

Year:  1994        PMID: 7848985      PMCID: PMC504974          DOI: 10.1136/bjo.78.11.863

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  26 in total

1.  Epikeratophakia for keratoconus. The nationwide study.

Authors:  M B McDonald; H E Kaufman; D S Durrie; R H Keates; D R Sanders
Journal:  Arch Ophthalmol       Date:  1986-09

2.  Histopathology of a case of epikeratophakia (aphakic epikeratoplasty).

Authors:  P S Binder; S D Baumgartner; J A Fogle
Journal:  Arch Ophthalmol       Date:  1985-09

3.  Anchoring fibrils form a complex network in human and rabbit cornea.

Authors:  I K Gipson; S J Spurr-Michaud; A S Tisdale
Journal:  Invest Ophthalmol Vis Sci       Date:  1987-02       Impact factor: 4.799

4.  Epikeratophakia for the treatment of keratoconus.

Authors:  H E Kaufman; T P Werblin
Journal:  Am J Ophthalmol       Date:  1982-03       Impact factor: 5.258

5.  Keratocyte survival following a controlled-rate freeze.

Authors:  T J Lee; W L Wan; R L Kash; K L Kratz; D J Schanzlin
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-09       Impact factor: 4.799

6.  Epikeratophakia for myopia correction.

Authors:  M B McDonald; S D Klyce; H Suarez; A Kandarakis; M H Friedlander; H E Kaufman
Journal:  Ophthalmology       Date:  1985-10       Impact factor: 12.079

7.  The correction of aphakia. XXXVI Edward Jackson Memorial Lecture.

Authors:  H E Kaufman
Journal:  Am J Ophthalmol       Date:  1980-01       Impact factor: 5.258

8.  Refractive keratoplasty. Tissue dyes and cryoprotective solutions.

Authors:  P S Binder; E Y Zavala; J Deg; P H Akers
Journal:  Arch Ophthalmol       Date:  1983-10

9.  The histopathology of a case of keratophakia.

Authors:  P S Binder; J P Beal; E Y Zavala
Journal:  Arch Ophthalmol       Date:  1982-01

10.  Hemidesmosome formation in vitro.

Authors:  I K Gipson; S M Grill; S J Spurr; S J Brennan
Journal:  J Cell Biol       Date:  1983-09       Impact factor: 10.539

View more
  1 in total

1.  Viability of keratocytes in epikeratophakia lenticules.

Authors:  H C Cheng; W J Armitage; M I Yagoubi; D L Easty
Journal:  Br J Ophthalmol       Date:  1996-04       Impact factor: 4.638

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.